Esmo Medical Oncology 2022

ESMO Congress 2022

https://www.esmo.org/meeting-calendar/past-meetings/esmo-congress-2022

The ESMO Congress 2022 presented the very latest advances in the treatment of cancer and offered an excellent educational programme, with opportunities for an exchange of …

European Society for Medical Oncology - ESMO

https://www.esmo.org/

The Molecular Analysis for Precision Oncology Congress 2022 (MAP) is the yearly appointment where leading experts discuss current and future challenges in the rapidly developing field of precision oncology, with the …

ESMO Examination for Medical Oncologists | Oncology …

https://www.esmo.org/career-development/esmo-examination

ESMO Congress 2022

https://oncologypro.esmo.org/meeting-resources/esmo-congress

Twelve ESMO Congress 2022 breakthroughs: practicing oncologists’ perceptions and potential application on presented data Published in ESMO Open, on …

Guidelines | ESMO

https://www.esmo.org/guidelines

2022 ESMO Designated Centres; Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris; How to re-accredit? Designated Centres Working Group; Cancer …

ESMO-ESO Course on Medical Oncology for Medical …

https://oncologypro.esmo.org/meeting-resources/esmo-eso-course-on-medical-oncology-for-medical-students-2022

15 Jul 2022 A Practical Approach to Cancer Diagnosis, Staging, Prognosis and Therapy Presenter: A. Cervantes, ES Session: SESSION 1 Principles of Cancer Therapy …

ESMO Immuno-Oncology Congress 2022

https://www.esmo.org/meeting-calendar/past-meetings/esmo-immuno-oncology-congress-2022

The ESMO Immuno-Oncology Congress is a global meeting offering an advanced educational programme and the latest scientific developments in this promising …

Abstracts | ESMO Immuno-Oncology Congress 2022

https://www.esmo.org/meeting-calendar/past-meetings/esmo-immuno-oncology-congress-2022/abstracts

Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 27 September 2022 will be considered for late-breaking status. …

ESMO for World Cancer Day 2022

https://www.esmo.org/about-esmo/joining-forces/esmo-for-world-cancer-day-2022

This year, World Cancer Day is launching “ #CloseTheCareGap ”, a 3-year campaign aiming to promote awareness, collaboration and action for a more equitable future in cancer …

Study EV-103 Cohort K: Antitumor activity of enfortumab …

https://oncologypro.esmo.org/meeting-resources/esmo-congress/study-ev-103-cohort-k-antitumor-activity-of-enfortumab-vedotin-ev-monotherapy-or-in-combination-with-pembrolizumab-p-in-previously-untreated-c

12 Sep 2022 LBA68 - Bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) compared to the investigator’s choice of sunitinib or cabozantinib in previously untreated advanced …